Clinical trial
Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese…
NCT00397176 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00397176 |
|---|---|
| Title | Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women |
| Official title | Ascending, Single Dose Study of the Safety, Tolerability, and Pharmacokinetics of DVS SR Administered Orally to Healthy Japanese Female Subjects |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Vasomotor Symptoms |
| Intervention type | Drug |
| Interventions | desvenlafaxine succinate sustained release (DVS SR) |
| Enrollment | 32 |
| Start date | Nov 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Nov 8, 2006 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: